Newsletter | February 10, 2026

02.10.26 -- Which Advanced Modalities Are Built For Commercial Scale In 2026?

SPONSOR

Webinar: The Future of CGT Manufacturing Panel Discussion: Integrating Digital Solutions With Regulatory Readiness

Join MasterControl for an expert panel on the future of cell and gene therapy (CGT) manufacturing. Learn how leading organizations are tackling regulatory complexity, cGMP execution, and digital transformation as CGT scales to commercialization. Gain practical strategies to embed quality at the source, harmonize global compliance, and leverage digital tools to build resilient, future-ready CGT operations. Click here to learn more.

FOCUS ON MANUFACTURING

Which Advanced Modalities Are Built For Commercial Scale In 2026?

In 2026, advanced therapies diverge: winners pair proven biology with scalable manufacturing, delivery, and workflow fit, while others advance more slowly under operational and economic limits.

Mastering The Complexity Of CGT Process Development

Master the complexities of cell and gene therapy by exploring scalability, automation, and process optimization. Gain expert insights to streamline your manufacturing and reach commercial success.

Pave The Way To High Productivity With Continuous Manufacturing For Pharma

Continuous manufacturing delivers agility and precision for pharma, combining automation, reduced manual steps, and quality control to meet regulatory and cost pressures while accelerating development.

Using Next Generation Sequencing Methods For Virus Vector Identity Testing

Sequencing techniques play a crucial role in establishing the quality attributes of a variety of therapeutic products. Learn what advantages NGS offers for obtaining accurate sequences.

Study Of Small Bioreactor Expansion Kinetics During Expansion Protocol

With significantly less cells and culture media, mesenchymal stem cells have been used to show equivalent expansion kinetics during a 7-day expansion protocol on both the small and standard bioreactors.

AACR 2025 Interview Series: Sizun Jiang

Discover Dr. Sizun Jiang's transformative insights on spatial technologies, AI-driven cancer care, and data harmonization, which illuminate the future of oncology through innovation.

Stick With Me: The Cool Chemistry Of HILIC Oligonucleotide Analysis

Check out this powerful alternative for analyzing polar sequences without ion-pairing reagents. By leveraging hydrophilic partitioning, achieve sharper separation and improved mass spectrometry compatibility.

Supporting The Future Of cGMP Drug Product Manufacturing

Delve into the benefits of holistic training and validation services, and how they help manufacturers navigate complex regulatory demands and achieve operational readiness faster.

How Colon Intestine-Chips Investigate Mechanisms Of Gastrointestinal Disease

Explore the application of Organ-Chips, what makes them superior to organoids in the study of GI-related diseases, and how they enable researchers to delve deeper into the mechanisms behind leaky gut syndrome.

Small Volume ATMP Cryo-Freezing Strategies

Elevate your knowledge on the best practices for cryopreserving small-volume ATMPs, especially when it comes to sterility, viability, and efficiency with advanced containers and packaging.

SPONSOR

Join Cell & Gene Live Chief Editor Erin Harris on February 19, at 11am Eastern for Building Smarter Cell Therapies with AI and Synthetic Biology. In this live event, experts will explore how AI and synthetic biology are being applied to engineer more precise, controllable, and scalable cell therapies. Register for free thanks to support from our sponsor BD Biosciences.

MANUFACTURING SOLUTIONS

Transfection Complex Stabilizer - Mirus Bio

Minimize Shear Forces On Cells - CARR Biosystems

CHO Edge System - Asimov

FGF-2 TOP GMP Thermostabilized Growth Factor - Nucleus Biologics

MSC Culture Media - Corning Life Sciences

Increased Productivity At Commercial Scale - Cytiva

Connect With Cell & Gene: